Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,905 | -27,439 | -15,849 | 141,923 | 165,999 |
| Depreciation Amortization | 17,228 | 11,999 | 6,401 | 37,429 | 27,090 |
| Income taxes - deferred | 10,964 | -8,418 | -5,200 | -8,280 | -4,934 |
| Accounts receivable | 7,596 | 19,658 | 9,331 | 68,638 | 24,214 |
| Accounts payable and accrued liabilities | -7,025 | -4,447 | -1,855 | -25,339 | -32,331 |
| Other Working Capital | -7,390 | 3,785 | -4,793 | 2,005 | -21,031 |
| Other Operating Activity | 31,602 | 6,692 | 4,058 | 37,144 | 61,306 |
| Operating Cash Flow | $12,070 | $1,830 | $-7,907 | $253,520 | $220,313 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 33,289 | 8,310 | -2,518 | -417,982 | -125,554 |
| PPE Investments | -18,661 | -13,760 | -1,836 | -18,363 | -13,813 |
| Net Acquisitions | N/A | N/A | N/A | -172,679 | -137,755 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -15,000 |
| Sale Of Investment | N/A | N/A | N/A | 372,710 | 133,407 |
| Other Investing Activity | 0 | 0 | 0 | -25,000 | -10,000 |
| Investing Cash Flow | $14,628 | $-5,450 | $-4,354 | $-261,314 | $-168,715 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,021 | -1,262 | -232 | -1,067 | -836 |
| Common Stock Issued | 3 | 3 | N/A | 31 | 19 |
| Common Stock Repurchased | -3,816 | -1,101 | -869 | -76,105 | -46,731 |
| Other Financing Activity | -15,000 | -15,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-21,834 | $-17,360 | $-1,101 | $-77,141 | $-47,548 |
| Exchange Rate Effect | -294 | -178 | 28 | -453 | -174 |
| Beginning Cash Position | 79,506 | 79,506 | 79,506 | 164,894 | 164,894 |
| End Cash Position | 84,076 | 58,348 | 66,172 | 79,506 | 168,770 |
| Net Cash Flow | $4,570 | $-21,158 | $-13,334 | $-85,388 | $3,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,070 | 1,830 | -7,907 | 253,520 | 220,313 |
| Capital Expenditure | -19,101 | -14,178 | -2,034 | -18,775 | -14,053 |
| Free Cash Flow | -7,031 | -12,348 | -9,941 | 234,745 | 206,260 |